Deodorant recall shocker! These everyday brands just failed major safety tests - is your brand on the list?
The safety rules are called Current Good Manufacturing Practices (CGMP), which make sure products are made in a clean and safe way. The recall was officially announced on July 10 by the company, as per the North Jersey report.
Explore courses from Top Institutes in
Select a Course Category
Finance
Management
MCA
Data Analytics
Cybersecurity
Operations Management
Product Management
CXO
Healthcare
Data Science
MBA
Artificial Intelligence
Leadership
Data Science
Digital Marketing
Degree
others
healthcare
PGDM
Design Thinking
Technology
Project Management
Others
Public Policy
Skills you'll gain:
Duration:
9 Months
IIM Calcutta
SEPO - IIMC CFO India
Starts on
undefined
Get Details
Skills you'll gain:
Duration:
7 Months
S P Jain Institute of Management and Research
CERT-SPJIMR Fintech & Blockchain India
Starts on
undefined
Get Details
The company didn't say exactly what was wrong or what health risks the deodorants could cause. The FDA warned people to stop using these products immediately. You should either throw them away or return them to the store you bought them from, as per the reports.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
New Container Houses Indonesia (Prices May Surprise You)
Container House | Search ads
Search Now
Undo
ALSO READ:
Navitas stock soars 33% to 52-week high — what's driving the surge in this semiconductor star?
Which Deodorants got recalled?
Power Stick for Her – Powder Fresh (1.8 oz)
UPC: 815195019313
21,265 cases recalled
Live Events
Power Stick Invisible Protection – Spring Fresh (1.8 oz)
UPC: 815195018194
22,482 cases recalled
ALSO READ:
Paranormal investigator dies after Annabelle doll tour – haunting curse resurfaces in 2025
Power Stick Original Nourishing Invisible Protection (1.8 oz)
UPC: 815195018224
23,467 cases recalled
These deodorants were sold all over the U.S., including big stores like Walmart and online on Amazon. If you want more info, check the FDA's website or contact the company directly, according to the report by North Jersey.
FAQs
Q1. Which Power Stick deodorants were recalled in July 2025?
Three Power Stick roll-on deodorants were recalled: Powder Fresh, Spring Fresh, and Original Nourishing, all in 1.8 oz size.
Q2. Why were Power Stick deodorants recalled by A.P. Deauville?
They were recalled for not following FDA's safety manufacturing rules, though exact problems weren't shared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
India to resume issuance of tourist visas to Chinese after 5-year hiatus
India said it will issue tourist visas to Chinese citizens from July 24, five years after it suspended the process, as the neighbouring nations seek to improve people-to-people ties amid decreasing border tensions. Chinese citizens can apply for a tourist visa to India by filling out an online application, scheduling an appointment and personally submitting their passport and other required documents to the Indian Visa Application Centres in Beijing, Shanghai and Guangzhou, the Embassy of India in China said in a statement Wednesday. Sources indicated that a vigil will be maintained so that the tourist visas are not misused. India had suspended all tourist visas in early 2020 in a bid to contain the spread of Covid-19. While New Delhi lifted restrictions on tourists from other countries as concerns over the pandemic eased, it did not resume issuing tourist visas to Chinese nationals as bilateral relations soured after the 2020 clashes in Ladakh's Galwan valley. The move now to resume the process comes ahead of Prime Minister Narendra Modi's proposed visit to China for the Shanghai Cooperation Organisation Summit early September. It also comes ahead of a plan to restart direct flights between the two countries. Explore courses from Top Institutes in Please select course: Select a Course Category Technology MCA Artificial Intelligence MBA Digital Marketing Public Policy Data Science Project Management Leadership Healthcare Data Science Management healthcare PGDM Finance others Others Operations Management Product Management Data Analytics Cybersecurity CXO Degree Design Thinking Skills you'll gain: Duration: 12 Weeks MIT xPRO CERT-MIT XPRO Building AI Prod India Starts on undefined Get Details Responding to the visa resumption, China said, "We take note of India's resumption of tourist visas for Chinese citizens. This is a positive move. Easing cross-border travel is widely beneficial. China will maintain communication & consultation with India to further facilitate travel between the two countries." Earlier this month, external affairs minister S Jaishankar met his Chinese counterpart Wang Yi in Beijing and raised the issue of restrictive trade measures and roadblocks to economic cooperation in the backdrop of restrictions on rare earth magnet supplies to India. He also brought up the issue of faster de-escalation along the Line of Actual Control in eastern Ladakh and the two sides agreed to take additional practical steps, including travel to each other's country and direct flight connectivity. Earlier this year, India and China explored ways to rebuild ties and agreed to initiate efforts to promote people-to-people exchanges, including resumption of the Kailash Manasarovar Yatra this year. Live Events
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
US bans flu shots with thimerosal in RFK Jr led vaccine policy shift
The United States will stop distributing all influenza vaccines that contain mercury-based preservative thimerosal, marking the latest move by US Health Secretary Robert F. Kennedy Jr. to reshape vaccine policy. Last month, a vaccine panel with members handpicked by Kennedy voted in favor of Americans receiving seasonal flu shots that are free from thimerosal, despite decades of studies showing no related safety issues. About 5 per cent of flu shots given in the US in the last flu season were multi-dose vials that contained the preservative, which was largely phased out decades ago. Anti-vaccine groups have for decades linked thimerosal to autism and other neurodevelopmental disorders, and Kennedy wrote a book in 2014 in which he advocated for "the immediate removal of mercury" from vaccines. The FDA on its website says "there was no evidence that thimerosal in vaccines was dangerous," and that the decision to remove it previously was a precautionary measure to decrease overall exposure to mercury among young infants. One of the panelists, who voted against the recommendation, had pointed out that the risk of not receiving the influenza vaccine because it contains thimerosal is greater than any known risks of the preservative. CSL's Afluria, and Flucelvax and Sanofi's Fluzone include thimerosal in multi-dose versions, according to the FDA's website. Kennedy accepted the panel's recommendation, the Department of Health and Human Services said on Wednesday, in the absence of the CDC director, who typically signs off on them before they are implemented. President Donald Trump's nominee for the CDC director, Susan Monarez, is yet to be confirmed by the US Senate. Other recommendations made by the panel, known as the Advisory Committee for Immunization Practices, at a meeting in June are still under review, the HHS said. Vaccine manufacturers have confirmed that they have the capacity to replace multi-dose vials containing the preservative, ensuring that supplies will not be interrupted, HHS said. Sanofi said it acknowledges the new policy and will have sufficient supply of the flu vaccine this season. CSL did not immediately respond to a Reuters request for comment.
Time of India
an hour ago
- Time of India
ADB trims FY26 growth forecast to 6.5% on baseline US duty impact
New Delhi: The Asian Development Bank (ADB) on Wednesday lowered India's growth forecast for FY26 to 6.5% from 6.7% citing the impact of baseline tariffs imposed by the United States and impact of policy uncertainty on investment. Despite the downgrade, India continues to be one of the fastest growing major economies globally. The Reserve Bank of India (RBI) also projected India's gross domestic product (GDP) growth at 6.5% for FY26 from 6.7% earlier. The Indian economy grew by 6.5% in FY25. Explore courses from Top Institutes in Please select course: Select a Course Category Finance Public Policy Data Science Artificial Intelligence Data Science Others MCA Digital Marketing Healthcare PGDM Technology Design Thinking Data Analytics healthcare Leadership MBA Operations Management CXO Product Management Cybersecurity Degree Management others Project Management Skills you'll gain: Duration: 9 Months IIM Calcutta SEPO - IIMC CFO India Starts on undefined Get Details Skills you'll gain: Duration: 7 Months S P Jain Institute of Management and Research CERT-SPJIMR Fintech & Blockchain India Starts on undefined Get Details According to the July Asian Development Outlook 2025, domestic economic activity remains resilient, supported by strong consumption, particularly from a revival in rural demand. "Services and agriculture sectors are expected to be key drivers of growth, the latter supported by a forecast of above-normal monsoon rains," it said. The Manufacturing and Services Purchasing Managers' Index (PMI) indicates stronger performance in India in the first quarter of this fiscal year, compared to other economies in the Asia Pacific region. ADB also noted that India's fiscal position remains healthy, aided by higher-than-expected dividends from the RBI. The central government is on track to meet its fiscal deficit reduction target. Live Events In comparison, growth projections for China, the largest economy in the region, are unchanged at 4.7% in 2025 and 4.3% in 2026. "Policy stimulus for consumption and industrial activity is expected to offset continuing property market weakness and softening exports," the ADB said. For South Asia, ADB revised the 2025 growth forecast down to 5.9% from 6% estimated in the April outlook. "Asia and the Pacific has weathered an increasingly challenging external environment this year. But the economic outlook has weakened amid intensifying risks and global uncertainty," said Albert Park, ADB chief economist. "Economies in the region should continue strengthening their fundamentals and promoting open trade and regional integration to support investment, employment, and growth," he added. Looking ahead, India's GDP growth is expected to improve to 6.7% in FY27 driven by rising investments, under the assumption of improved policy clarity and favourable financial conditions, following recent monetary easing. "The baseline expectations of lower crude oil prices will also support economic activity in FY2025 and FY2026," said the ADB. In June, the RBI's monetary policy committee (MPC) cut the repo rate by 50 basis points to 5.5% and reduced cash reserve ratio by 100 bps to 3%, adding ₹2.5 lakh crore in liquidity into the banking next MPC meeting is scheduled for the first week of August. ADB also revised its inflation forecast for India to 3.8% in FY26 from 4.3% estimated earlier, "reflecting faster-than-expected decline in food prices due to better agricultural production." Ind-Ra cuts FY26 forecast to 6.3% India Ratings and Research (Ind-Ra) Wednesday revised India's growth forecast for FY26 to 6.3% from the previous estimate of 6.6%, due to tariff hikes by the US and a weaker investment climate. The Indian economy is facing both headwinds and tailwinds. "Major headwinds are uncertain global scenario from the unilateral tariff hikes by the US for all countries and weaker-than-expected investment climate," said DK Pant, chief economist and head public finance at Ind-Ra. "The major tailwinds are monetary easing, faster-than-expected inflation decline, and likely above-normal rainfall in 2025," he added.
